KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) FCF Margin (2016 - 2025)

Zimmer Biomet Holdings has reported FCF Margin over the past 17 years, most recently at 19.73% for Q4 2025.

  • Quarterly results put FCF Margin at 19.73% for Q4 2025, down 275.0% from a year ago — trailing twelve months through Dec 2025 was 17.89% (up 102.0% YoY), and the annual figure for FY2025 was 17.89%, up 102.0%.
  • FCF Margin for Q4 2025 was 19.73% at Zimmer Biomet Holdings, up from 18.17% in the prior quarter.
  • Over the last five years, FCF Margin for ZBH hit a ceiling of 27.09% in Q4 2023 and a floor of 9.15% in Q1 2024.
  • Median FCF Margin over the past 5 years was 16.94% (2022), compared with a mean of 17.46%.
  • Peak annual rise in FCF Margin hit 2822bps in 2021, while the deepest fall reached -1068bps in 2021.
  • Zimmer Biomet Holdings' FCF Margin stood at 16.23% in 2021, then plummeted by -39bps to 9.91% in 2022, then skyrocketed by 173bps to 27.09% in 2023, then fell by -17bps to 22.48% in 2024, then dropped by -12bps to 19.73% in 2025.
  • The last three reported values for FCF Margin were 19.73% (Q4 2025), 18.17% (Q3 2025), and 15.79% (Q2 2025) per Business Quant data.